we are using more mris guided by biopsies. we can locate where the cancer is instead of shooting in the dark. that is a big part of this ultrasound can miss. what they found among obese patients, high grade pre-cancerous legions. and other interesting part of this the western diet it's about red meat, sugar and fat as opposed to fruits and vegetables. more prostate cancer happens in americans to japanese. but when japanese migrate to u.s. prostate cancer goes up. so diet plays a huge role. stay away from red meat. >> steak, hamburger once or twice a week? >> once or twice a week is not going to change. but if you are real red meat eater and lots of sugar in your diet. >> so there a truth about diet. >> red meat and sugar. >> heather: you are what you eat? >> yes, exactly. the mediterranean diet. with the olive oil and fish and chicken. >> it does work. >> eric: coming up new research on how to treat your children when they are sick. sunday house calls tell us what they need to know before you go to the medicine cabinet. we'll

in this country we perform 1.2 million prostate biopsies a year. and it's possibly 750,000 of them might not be necessarily. and 2.5 billion each year and all people are terrified they have prostate cancer and things can go wrong when they go inside your body. here's where opko comes in. the company developed a new psa test with additional markers and significantly more accurate than the current standard. if we adopt okpo's test, it could cut the number of unnecessary biopsies in half and it could do 1.8 billion in peak sales, and alzheimer's, type one diabetes, and it launched in europe this past october and the company expects to launch it here in the united states sometime in this quarter, also other competing drugs and "the new york times" mentioned that, have to point it out. the company also has in the pipeline a rapid fire diagnostic test, developing for other diseases like nonsmall cell lung cancer, pan creatic cancer. and they are trying to suppress nausea in chemotherapy. and this could be approved next year and might do peek sales of ove

if we adopt okpo's test, it could cut the number of unnecessary biopsies in half and it could do 1.8 million in peek sales, and alzheimer's, type one diabetes, and it launched in europe this past october and the company expects to launch it here in the united states sometime in this quarter, also other competing drugs and "the new york times" mentioned that, have to point it out. and rapid fire diagnostic tests, developing for other diseases like nonsmall cell lung cancer, bank pancreatic cancer. and they are trying to suppress nausea in chemo therapy. and this could be approved next year and might do peek sales of over 1 million, you know how it makes you so nauseous and two wholly owned drugs in phase three development. they have one for parkinson's in the pipeline. and the management factor. the ceo of opko is the man with the midas touch. over the last 30 years, he's founded and sold two drug companies, first key pharma, bought by sheariering plough. and then ivix. 6,000% profit when frost sold the company. he doesn't just run opko, he owns 46% of the company and he bought a ton

she sent me right in for a biopsy, which, of course, unfortunately proved positive and i was diagnosed with stage iii lobular breast cancer at the age of 36 or 37. cancer detection methods vary depending on the location of a suspected cancer. oral cancers, for example, can be detected by visual examination. some cancers are found by collecting cells from microscopic examination. this is what happens when a woman gets a pap test for cervical cancer. colon cancer and stomach cancer can be identified with the help of fiberoptic technology. a flexible tube called a fiberscope is inserted in the area under investigation. the fibers transmit an image from the lighted end of the scope to an eyepiece or monitor. other cancers that grow within tissues, such as breast cancer and lung cancer, can be detected by x-rays. ct scans and mri's can also be used to find deeply embedded cancers, such as brain cancer. i don't rember being anything but sort of shocked. i couldn't believe it. i had no-- there were no risk factors in my family other than my father, and he was anomalous. i was so healthy, and

they can do a biopsy on the brain now, the older guy, and they can find the evidence of cte easily. and now they were able to do this at ucla. they can do it on living people. >> i will make a prediction. >> and then it might blowup as a story at this point. i think the problem here is ism, in the name of an ism. that's the most dangerous thing. >> i am also against any type of prescription drug along those lines. i said this before and will say it again. the only drug that has done harm to anyone is cocaine. something to think about. >> that was a code to his dealer to meet him out behind the building. >> 930a and 936a. >> when they analyze his brain i will bet you a thousand dollars they will notice it sucks. >> that's diagnosis. >> it is pre hails himmers or -- it is pre alzheimer's or whatever else. >> i correct, it is about isms, people driven by isms. >> of course it is. >> one can be worse than the other. >> not all are equal. that's a bumper sticker. they are yelling at me. coming up, a story so exciting i forgot to write a tease about it. but first, are we going to do this

. >> this will allow us to actually in realtime get a biopsy from a patient's tumor. and then we can load the printer with the different cell types and actually reprint the person's tissue and then in realtime within a week be able to test it and see what it responds to. >> reporter: seers thinks within a year the printer could be used to help figure out which drug can best target an individual's cancer, leading to customized and successful cancer treatments. >> i'm really excited about this because it could revolutionize how we do personalized medicine and treatment. >> reporter: and she isn't the only one excited. larry bonasauer of cornell. >> people are very interested in this for things like alzheimers and parkinsons as well as motor defect in the spinal cord. printing is a potentially blockbuster development because patterning the cells in a way that makes sense that the body needs to pattern is really critical. and this is a fantastic tool to be able to do that. >> reporter: from new treatments for cancer to some day new organs, your future may be a matter of s